Dr. Yoram Richter has been with Medinol since 1994, and serves as its Chief Scientific Officer, he is responsible for future research and development projects. In addition to his role at Medinol, Dr. Richter is Vice President for Research and Development at BIOrest, a company developing a targeted systemic anti-inflammatory drug for cardiovascular and other indications. He is also Chief Scientific Officer of Microtech – a company developing sub millimeter implantable sensors – and Chief Scientific Officer of Valve Medical – a company developing a unique percutaneous aortic valve.
Dr. Richter holds a B.Sc. in Physics and Computer Sciences from Tel Aviv University, an M.Sc. in Electrical Engineering from the Massachusetts Institute of Technology, and a Ph.D. in Medical Engineering from Massachusetts Institute of Technology. His Ph.D. thesis concentrated on the physical and biological processes leading to atherosclerosis and published important papers and editorials on the subject of bifurcation treatment.